针对糖尿病患者的人工智能和基于大数据的个性化慢性疾病管理模型的应用研究
Mei Xin1, Yanbing Yao2, Ping Huang1
1Department of Health Management, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Frontiers in public health
|February 16, 2026
概括
与传统护理相比,人工智能驱动的个性化慢性疾病管理模型显著改善了2型糖尿病患者的血糖控制,自我护理和生活质量. 成功因素包括生活方式的选择和遵守监控计划.
科学领域:
- 数字健康数字健康
- 人工智能在医学中的应用
- 慢性疾病管理 慢性疾病管理
背景情况:
- 2型糖尿病 (T2DM) 管理需要有效的患者支持.
- 传统的护士主导的护理在个性化慢性疾病管理方面存在局限性.
- 人工智能和大数据为增强T2DM患者管理提供了潜力.
研究的目的:
- 评估人工智能和大数据驱动的个人化慢性疾病管理模型对T2DM患者的实际有效性.
- 将人工智能模型的结果与传统的护士领导的管理进行比较.
- 在人工智能驱动的个性化模型中识别影响血糖控制的因素.
主要方法:
- 一项对280名T2DM患者进行的回顾性队列研究,比较了传统 (n=100) 和个性化 (n=180) 管理组6个月的时间.
- 个性化小组使用人工智能模型 (XGBoost,强化学习) 通过移动应用程序进行动态的,个性化的计划.
- 评估包括血糖控制 (FBG,2hPG,HbA1c),自我护理 (SDSCA) 和生活质量 (DSQL).
主要成果:
- 与传统组相比,个性化管理组显示出显著更好的血糖控制 (更低的FBG,2hPG,HbA1c) 和更好的自我护理和生活质量得分.
- 在个性化小组中,酒精消费,低HDL-C和不良的葡萄糖监测遵守是控制不良的风险因素.
- 在个性化小组中,更高的炼计划完成是血糖控制的保护因素.
结论:
- 人工智能和大数据驱动的个性化管理在6个月内显著提高了T2DM患者的血糖控制,自我护理行为和生活质量.
- 行为因素 (酒精消耗,运动坚持) 和生物因素 (HDL-C) 在AI模型中影响T2DM管理的成功.
- 这种由人工智能驱动的方法显示出改善糖尿病护理和患者结果的希望.
相关概念视频
Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Methods of Documentation VI: Case Management Model
966
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
966
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Issues And Trends In Healthcare Delivery System
6.3K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K
Chronic Kidney Disease III: Interprofessional Care
492
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
492
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
